Lagunita Biosciences

Lagunita BioSciences is a venture capital firm in California that focuses on ophthalmology, protein engineering and drug discovery, surgical devices, optical diagnostics and therapeutics and mobile health. Founded 2015 in Menlo Park, California, United States, it invests in series A, series B and series C rounds. Its portfolio companies include Kedalion Therapeutics, Verana Health, and ViewPoint Therapeutics. As of March 2020, Lagunita BioSciences LLC has made five investments. This venture capital company’s most recent investment was on August 6, 2018, when Kedalion Therapeutics raised $5M.